Healthcare >> Analyst Interviews >> August 6, 2001

Drug Delivery Stocks: Louis Webb Jr. – Dain Rauscher Wessels

LOUIS C. WEBB, JR., is a Principal with Dain Rauscher Wessels, focusing on drug delivery and specialty pharmaceuticals as part of the Life Sciences equity research team. He has 25 years' experience following the pharmaceutical sector, including four years as Vice President, research at Fahnestock & Co. and six years as First Vice President, research at Robert W. Baird & Co. Mr. Webb received a Bachelor of Science degree in Engineering and Applied Science from Yale University in 1975 and became a Chartered Financial Analyst in 1980. He is a member of AIMR and the NYSSA. In The Wall Street Journal annual analyst survey, Mr. Webb ranked first in pharmaceutical stock picking in 2000 and first in pharmaceutical earnings estimate accuracy in 1996. Mr. Webb lives in Ossining, New York, and includes sailing among his personal interests. Profile
TWST: Louis, what do investors need to understand about drug delivery

stocks? Where do they fit in the pharmaceutical arena?

Mr. Webb: We view the drug delivery sector as offering